Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T49064
|
||||
Former ID |
TTDS00429
|
||||
Target Name |
Gastric triacylglycerol lipase
|
||||
Gene Name |
LIPF
|
||||
Synonyms |
GL; Gastric lipase; LIPF
|
||||
Target Type |
Clinical Trial
|
||||
Disease | Diabetes; Obesity [ICD9: 250, 278; ICD10: E08-E13, E66] | ||||
BioChemical Class |
Carboxylic ester hydrolase
|
||||
UniProt ID | |||||
EC Number |
EC 3.1.1.3
|
||||
Sequence |
MWLLLTMASLISVLGTTHGLFGKLHPGSPEVTMNISQMITYWGYPNEEYEVVTEDGYILE
VNRIPYGKKNSGNTGQRPVVFLQHGLLASATNWISNLPNNSLAFILADAGYDVWLGNSRG NTWARRNLYYSPDSVEFWAFSFDEMAKYDLPATIDFIVKKTGQKQLHYVGHSQGTTIGFI AFSTNPSLAKRIKTFYALAPVATVKYTKSLINKLRFVPQSLFKFIFGDKIFYPHNFFDQF LATEVCSREMLNLLCSNALFIICGFDSKNFNTSRLDVYLSHNPAGTSVQNMFHWTQAVKS GKFQAYDWGSPVQNRMHYDQSQPPYYNVTAMNVPIAVWNGGKDLLADPQDVGLLLPKLPN LIYHKEIPFYNHLDFIWAMDAPQEVYNDIVSMISEDKK |
||||
Structure |
1HLG
|
||||
Drugs and Mode of Action | |||||
Drug(s) | Cetilistat | Drug Info | Phase 3 | Diabetes; Obesity | [1], [2] |
Inhibitor | B-Octylglucoside | Drug Info | [3] | ||
Undecyl-Phosphinic Acid Butyl Ester | Drug Info | [4] | |||
Modulator | Cetilistat | Drug Info | [1] | ||
Pathways | |||||
BioCyc Pathway | Triacylglycerol degradation | ||||
KEGG Pathway | Glycerolipid metabolism | ||||
Metabolic pathways | |||||
Fat digestion and absorption | |||||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
WikiPathways | Triacylglyceride Synthesis | ||||
Fatty Acid Beta Oxidation | |||||
References | |||||
REF 1 | Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes (Lond). 2007 Mar;31(3):494-9. Epub 2006 Sep 5. | ||||
REF 2 | Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. | ||||
REF 3 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | ||||
REF 4 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.